ARCHIVES

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

This article is from The Cancer Letter archive.

Vol. 18 No. 29 | July 17, 1992

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo

September 26, 2003

Prevention Program Being Developed For Primary Providers

January 29, 1988

In Brief: Preyer, Waxman Battle Over Chairmanship Of Health Group; Amos To Head Mas. ACS

January 12, 1979

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

Gallo Actively Searching For New Position

July 1, 1994